WinstonWınston
Back
Biosenta logo

Biosenta

ZRO.CN
Household & Personal Products · Consumer Defensive
Price
C$0.06
-0.01 (-8.33%)
Market Cap
C$1.9M
Exchange
Canadian Securities Exchange
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+86.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 17.8M (2021) → 33.3M (2025)

Winston Score History

The full picture

Biosenta Inc. is a small Canadian company that makes cleaning and disinfecting products designed to be safer for people and the environment. Its core products are surface sanitizers and disinfectants sold to businesses, institutions, and consumers who want effective cleaning solutions without harsh chemicals. The company operates in the household and personal products industry, competing in the growing segment of eco-friendly and non-toxic cleaning products.

Biosenta earns money by selling its cleaning products directly and through distribution partners, primarily in Canada. The company is very small, with a market cap near zero, and is still in an early stage of building its business — its deeply negative operating margin shows it is spending far more than it earns right now. The main risk is that Biosenta must scale up sales quickly to survive, as it faces intense competition from large, established cleaning product brands that have much greater resources and shelf space.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

>+1,000% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

+21.8% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

C$33,524/ year

Declining (-19% vs prior year)

>1,000% of revenue

1384.1x the sector average (2%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

49.4%ownership

Insiders own a meaningful stake in the company

Cash Runway

~0 months

C$10,376 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Strong grower

Biosenta is growing revenue at 1012% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
14.2%
Thin — 14.2% gross margin
Profit after running costs
Operating Margin
-11057.9%
Losing money on operations — -11057.9%
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+118.5%
Fast-growing sales (+118.5% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-10997.3%
Burning cash (-10997.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial